National Academies Press: OpenBook

An Assessment of the SBIR Program at the National Institutes of Health (2009)

Chapter: Appendix A: NIH SBIR Program Data

« Previous: 5 Program Management at NIH
Suggested Citation:"Appendix A: NIH SBIR Program Data." National Research Council. 2009. An Assessment of the SBIR Program at the National Institutes of Health. Washington, DC: The National Academies Press. doi: 10.17226/11964.
×

Appendixes

Suggested Citation:"Appendix A: NIH SBIR Program Data." National Research Council. 2009. An Assessment of the SBIR Program at the National Institutes of Health. Washington, DC: The National Academies Press. doi: 10.17226/11964.
×

This page intentionally left blank.

Suggested Citation:"Appendix A: NIH SBIR Program Data." National Research Council. 2009. An Assessment of the SBIR Program at the National Institutes of Health. Washington, DC: The National Academies Press. doi: 10.17226/11964.
×

Appendix A
NIH SBIR Program Data

NOTES:


“Year one” awards: NIH maintains data by fiscal year, and in a number of cases changes award number between years. As a result, it is often hard to track a complete award from first year to last. Our approach has therefore been to focus on “award years,” identifying for example the first year of each award for analysis. This focus provides a complete data set for all NIH awards, and also allows analysis of awards in subsequent years of support.


Following discussions with the NRC staff, the NIH made an effort to recalculate the data for woman and minority owners’ participation in the SBIR program. In September, 2007, the NIH provided corrected data, which is shown in Appendix A and in several figures in this report. However, apparent anomalies in the NIH data on the participation of women and minorities in 2001-2002 could not be resolved by the time of publication of this report.

Suggested Citation:"Appendix A: NIH SBIR Program Data." National Research Council. 2009. An Assessment of the SBIR Program at the National Institutes of Health. Washington, DC: The National Academies Press. doi: 10.17226/11964.
×

BOX App-A-1

Institute and Center Codes for the National Institutes of Health

In data tables throughout this report, the following codes are used to reference National Institutes of Health institutes and centers.

Code

Institute Name and Acronym

AA

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

AG

National Institute on Aging (NIA)

AI

National Institute of Allergy and Infectious Diseases (NIAID)

AR

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

AT

National Center for Complementary and Alternative Medicine (NCCAM)

CA

National Cancer Institute (NCI)

DA

National Institute on Drug Abuse (NIDA)

DC

National Institute on Deafness and Other Communication Disorders (NIDCD)

DE

National Institute of Dental & Craniofacial Research (NIDCR)

DK

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

EB

National Institute of Biomedical Imaging and Bioengineering (NIBIB)

ES

National Institute of Environmental Health Sciences (NIEHS)

EY

National Eye Institute (NEI)

GM

National Institute of General Medical Sciences (NIGMS)

HD

National Institute of Child Health and Human Development (NICHD)

HG

National Human Genome Research Institute (NHGRI)

HL

National Heart, Lung and Blood Institute (NHLBI)

LM

National Library of Medicine (NLM)

MD

National Center on Minority Health and Health Disparities (NCMHD)

MH

National Institute of Mental Health (NIMH)

NR

National Institute of Nursing Research (NINR)

NS

National Institute of Neurological Disorders and Stroke (NINDS)

RR

National Center for Research Resources (NCRR)

TW

Fogarty International Center (FIC)

Suggested Citation:"Appendix A: NIH SBIR Program Data." National Research Council. 2009. An Assessment of the SBIR Program at the National Institutes of Health. Washington, DC: The National Academies Press. doi: 10.17226/11964.
×

TABLE App-A-1 Applications: Phase I and Phase II, 1992-2005

Phase I

Phase II

Fiscal Year

All Applications (#)

Total Funded (#)

Success Rate (%)

Fiscal Year

All Applications (#)

Total Funded (#)

Success Rate (%)

1992

1,982

541

27.3

1992

551

278

50.5

1993

2,297

594

25.9

1993

637

360

56.5

1994

3,225

530

16.4

1994

744

351

47.2

1995

3,453

624

18.1

1995

780

370

47.4

1996

3,051

525

17.2

1996

798

390

48.9

1997

2,789

743

26.6

1997

800

468

58.5

1998

2,689

717

26.7

1998

827

541

65.4

1999

3,430

908

26.5

1999

897

539

60.1

2000

3,907

986

25.2

2000

1,023

587

57.4

2001

3,203

940

29.3

2001

1,074

683

63.6

2002

3,735

1,001

26.8

2002

1,248

797

63.9

2003

4,812

1,137

23.6

2003

1,299

788

60.7

2004

5,856

1,150

19.6

2004

1,410

792

56.2

2005

5,071

937

18.5

2005

1,451

774

53.3

SOURCE: National Institutes of Health.

Suggested Citation:"Appendix A: NIH SBIR Program Data." National Research Council. 2009. An Assessment of the SBIR Program at the National Institutes of Health. Washington, DC: The National Academies Press. doi: 10.17226/11964.
×

TABLE App-A-2 Phase I Applications by IC, 1992-2004

IC

Number of Applications

1992

1993

1994

1995

1996

1997

1998

1999

2000

2001

2002

2003

2004

AA

25

52

38

37

50

53

30

40

39

24

29

65

62

AG

84

94

149

159

146

122

105

103

134

130

95

134

162

AI

154

201

350

413

349

333

290

365

461

356

592

676

844

AR

111

101

165

126

167

126

127

132

173

152

142

169

201

AT

 

 

 

 

 

 

 

5

36

58

55

41

35

CA

334

349

607

559

507

514

465

663

817

695

701

889

1,173

DA

59

45

74

92

78

56

57

80

74

75

70

90

112

DC

44

47

68

69

51

41

45

65

60

45

38

60

65

DE

71

80

67

64

63

49

61

70

89

84

57

57

83

DK

107

121

164

201

180

150

179

261

267

211

255

335

376

EB

 

 

 

 

 

 

 

 

 

 

71

247

331

ES

46

48

47

83

62

51

45

44

67

79

115

114

133

EY

93

85

130

135

119

78

75

105

84

52

66

104

124

GM

157

226

204

215

219

203

207

254

248

234

234

313

387

HD

121

198

224

236

184

168

178

212

206

128

171

245

305

HG

24

18

36

35

33

29

42

57

42

27

53

68

67

HL

221

228

336

382

356

347

334

430

478

375

386

472

528

LM

10

27

24

27

40

57

36

53

40

32

38

53

59

MD

 

 

 

 

 

 

 

 

 

 

 

1

8

MH

93

90

135

191

152

124

120

124

122

110

120

148

172

NR

39

65

66

61

37

16

22

23

19

17

22

16

37

NS

85

95

129

123

113

105

129

148

187

132

162

221

225

RR

102

123

209

240

141

166

128

179

222

170

190

198

242

Total

1,980

2,293

3,222

3,448

3,047

2,788

2,675

3,413

3,865

3,186

3,662

4,716

5,731

Suggested Citation:"Appendix A: NIH SBIR Program Data." National Research Council. 2009. An Assessment of the SBIR Program at the National Institutes of Health. Washington, DC: The National Academies Press. doi: 10.17226/11964.
×

IC

Percentage of All Applications

1992

1993

1994

1995

1996

1997

1998

1999

2000

2001

2002

2003

2004

AA

1.3

2.3

1.2

1.1

1.6

1.9

1.1

1.2

1.0

0.8

0.8

1.4

1.1

AG

4.2

4.1

4.6

4.6

4.8

4.4

3.9

3.0

3.5

4.1

2.6

2.8

2.8

AI

7.8

8.8

10.9

12.0

11.5

11.9

10.8

10.7

11.9

11.2

16.2

14.3

14.7

AR

5.6

4.4

5.1

3.7

5.5

4.5

4.7

3.9

4.5

4.8

3.9

3.6

3.5

AT

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.1

0.9

1.8

1.5

0.9

0.6

CA

16.9

15.2

18.8

16.2

16.6

18.4

17.4

19.4

21.1

21.8

19.1

18.9

20.5

DA

3.0

2.0

2.3

2.7

2.6

2.0

2.1

2.3

1.9

2.4

1.9

1.9

2.0

DC

2.2

2.0

2.1

2.0

1.7

1.5

1.7

1.9

1.6

1.4

1.0

1.3

1.1

DE

3.6

3.5

2.1

1.9

2.1

1.8

2.3

2.1

2.3

2.6

1.6

1.2

1.4

DK

5.4

5.3

5.1

5.8

5.9

5.4

6.7

7.6

6.9

6.6

7.0

7.1

6.6

EB

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

1.9

5.2

5.8

ES

2.3

2.1

1.5

2.4

2.0

1.8

1.7

1.3

1.7

2.5

3.1

2.4

2.3

EY

4.7

3.7

4.0

3.9

3.9

2.8

2.8

3.1

2.2

1.6

1.8

2.2

2.2

GM

7.9

9.9

6.3

6.2

7.2

7.3

7.7

7.4

6.4

7.3

6.4

6.6

6.8

HD

6.1

8.6

7.0

6.8

6.0

6.0

6.7

6.2

5.3

4.0

4.7

5.2

5.3

HG

1.2

0.8

1.1

1.0

1.1

1.0

1.6

1.7

1.1

0.8

1.4

1.4

1.2

HL

11.2

9.9

10.4

11.1

11.7

12.4

12.5

12.6

12.4

11.8

10.5

10.0

9.2

LM

0.5

1.2

0.7

0.8

1.3

2.0

1.3

1.6

1.0

1.0

1.0

1.1

1.0

MD

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.1

MH

4.7

3.9

4.2

5.5

5.0

4.4

4.5

3.6

3.2

3.5

3.3

3.1

3.0

NR

2.0

2.8

2.0

1.8

1.2

0.6

0.8

0.7

0.5

0.5

0.6

0.3

0.6

NS

4.3

4.1

4.0

3.6

3.7

3.8

4.8

4.3

4.8

4.1

4.4

4.7

3.9

RR

5.2

5.4

6.5

7.0

4.6

6.0

4.8

5.2

5.7

5.3

5.2

4.2

4.2

Total

100.0

100.0

100.0

100.0

100.0

100.0

100.0

100.0

100.0

100.0

100.0

100.0

100.0

SOURCE: National Institutes of Health.

Suggested Citation:"Appendix A: NIH SBIR Program Data." National Research Council. 2009. An Assessment of the SBIR Program at the National Institutes of Health. Washington, DC: The National Academies Press. doi: 10.17226/11964.
×

TABLE App-A-3 Applications by IC—Phase II, 1992-2004

 

Number of Applications

 

1992

1993

1994

1995

1996

1997

1998

1999

2000

2001

2002

2003

2004

AA

11

9

5

9

6

14

6

9

9

3

6

5

20

AA

AG

38

24

19

27

22

16

21

26

30

27

26

24

32

AG

AI

41

44

47

56

47

57

59

64

58

60

66

68

100

AI

AR

19

17

14

12

16

22

19

24

26

23

35

24

14

AR

AT

 

 

 

 

 

 

 

1

1

1

4

3

10

AT

CA

43

97

148

166

134

110

72

95

123

117

126

147

159

CA

DA

11

18

10

16

15

29

21

16

18

27

24

27

29

DA

DC

7

15

9

14

11

6

8

11

11

19

26

14

27

DC

DE

16

13

10

11

13

10

7

13

7

14

33

28

20

DE

DK

25

36

21

24

34

48

29

35

30

52

57

59

58

DK

EB

 

 

 

 

 

 

 

 

 

 

14

11

18

EB

ES

9

15

5

9

8

6

12

10

9

11

17

24

31

ES

EY

17

17

11

26

21

27

24

21

19

16

13

30

27

EY

GM

37

25

44

53

45

47

38

46

56

63

44

69

81

GM

HD

23

23

43

43

36

39

29

48

51

42

42

45

55

HD

HG

3

5

3

7

3

5

4

11

10

8

6

11

12

HG

HL

61

73

62

59

72

91

87

98

66

105

114

130

94

HL

LM

1

1

3

1

 

 

 

2

4

3

2

3

 

LM

MD

 

 

 

 

 

 

 

 

 

 

 

1

 

MD

MH

20

16

23

22

28

28

27

36

39

37

21

33

45

MH

NR

4

7

2

6

6

2

1

4

5

5

5

4

4

NR

NS

16

24

14

23

37

37

32

29

39

54

49

30

39

NS

RR

7

10

29

35

21

18

8

28

42

45

42

41

33

RR

Total

409

489

522

619

575

612

504

627

653

732

772

831

908

 

Suggested Citation:"Appendix A: NIH SBIR Program Data." National Research Council. 2009. An Assessment of the SBIR Program at the National Institutes of Health. Washington, DC: The National Academies Press. doi: 10.17226/11964.
×

 

Percentage of Total Applications, by IC

1992

1993

1994

1995

1996

1997

1998

1999

2000

2001

2002

2003

2004

92-03

AA

2.7

1.8

1.0

1.5

1.0

2.3

1.2

1.4

1.4

0.4

0.8

0.6

2.2

1.3

AG

9.3

4.9

3.6

4.4

3.8

2.6

4.2

4.1

4.6

3.7

3.4

2.9

3.5

4.1

AI

10.0

9.0

9.0

9.0

8.2

9.3

11.7

10.2

8.9

8.2

8.5

8.2

11.0

9.1

AR

4.6

3.5

2.7

1.9

2.8

3.6

3.8

3.8

4.0

3.1

4.5

2.9

1.5

3.4

AT

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.2

0.2

0.1

0.5

0.4

1.1

0.1

CA

10.5

19.8

28.4

26.8

23.3

18.0

14.3

15.2

18.8

16.0

16.3

17.7

17.5

18.8

DA

2.7

3.7

1.9

2.6

2.6

4.7

4.2

2.6

2.8

3.7

3.1

3.2

3.2

3.2

DC

1.7

3.1

1.7

2.3

1.9

1.0

1.6

1.8

1.7

2.6

3.4

1.7

3.0

2.1

DE

3.9

2.7

1.9

1.8

2.3

1.6

1.4

2.1

1.1

1.9

4.3

3.4

2.2

2.4

DK

6.1

7.4

4.0

3.9

5.9

7.8

5.8

5.6

4.6

7.1

7.4

7.1

6.4

6.1

EB

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

1.8

1.3

2.0

0.3

ES

2.2

3.1

1.0

1.5

1.4

1.0

2.4

1.6

1.4

1.5

2.2

2.9

3.4

1.8

EY

4.2

3.5

2.1

4.2

3.7

4.4

4.8

3.3

2.9

2.2

1.7

3.6

3.0

3.3

GM

9.0

5.1

8.4

8.6

7.8

7.7

7.5

7.3

8.6

8.6

5.7

8.3

8.9

7.7

HD

5.6

4.7

8.2

6.9

6.3

6.4

5.8

7.7

7.8

5.7

5.4

5.4

6.1

6.3

HG

0.7

1.0

0.6

1.1

0.5

0.8

0.8

1.8

1.5

1.1

0.8

1.3

1.3

1.0

HL

14.9

14.9

11.9

9.5

12.5

14.9

17.3

15.6

10.1

14.3

14.8

15.6

10.4

13.9

LM

0.2

0.2

0.6

0.2

0.0

0.0

0.0

0.3

0.6

0.4

0.3

0.4

0.0

0.3

MD

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.1

0.0

0.0

MH

4.9

3.3

4.4

3.6

4.9

4.6

5.4

5.7

6.0

5.1

2.7

4.0

5.0

4.5

NR

1.0

1.4

0.4

1.0

1.0

0.3

0.2

0.6

0.8

0.7

0.6

0.5

0.4

0.7

NS

3.9

4.9

2.7

3.7

6.4

6.0

6.3

4.6

6.0

7.4

6.3

3.6

4.3

5.2

RR

1.7

2.0

5.6

5.7

3.7

2.9

1.6

4.5

6.4

6.1

5.4

4.9

3.6

4.4

Total

100.0

100.0

100.0

100.0

100.0

100.0

100.0

100.0

100.0

100.0

100.0

100.0

100.0

100.0

SOURCE: National Institutes of Health.

Suggested Citation:"Appendix A: NIH SBIR Program Data." National Research Council. 2009. An Assessment of the SBIR Program at the National Institutes of Health. Washington, DC: The National Academies Press. doi: 10.17226/11964.
×

TABLE App-A-4 Woman- and Minority-owned Firms—Application Shares, 1992-2006 (percent of all applications)

Fiscal Year

Woman-owned Firms

Fiscal Year

Minority-owned Firms

Phase I (%)

Phase II (%)

All (%)

Phase I (%)

Phase II (%)

All (%)

1992

12.2

13.0

12.3

1992

10.3

5.6

9.5

1993

8.0

9.0

8.2

1993

6.9

5.7

6.7

1994

9.3

7.3

9.0

1994

9.6

7.9

9.4

1995

12.6

7.1

11.8

1995

9.1

8.1

9.0

1996

11.8

9.9

11.5

1996

10.0

5.4

9.3

1997

10.2

9.8

10.1

1997

8.0

5.5

7.6

1998

8.3

8.4

8.3

1998

5.5

5.6

5.5

1999

10.8

12.8

11.1

1999

7.8

5.5

7.3

2000

9.8

13.9

10.5

2000

5.4

5.7

5.5

2001

4.5

4.7

4.6

2001

2.9

3.1

2.9

2002

2.6

3.0

2.7

2002

1.2

1.5

1.3

2003

11.1

10.8

11.0

2003

7.0

4.1

6.4

2004

11.4

11.7

11.5

2004

7.3

5.1

6.9

2005

10.6

11.9

10.9

2005

5.3

4.8

5.2

2006

12.9

12.8

12.9

2006

6.7

4.0

6.1

SOURCE: National Institutes of Health.

TABLE App-A-5 Woman- and Minority-owned Firms—Award Shares, 1992-2006 (percent of all awards)

Fiscal Year

Woman-owned Firms Award Share (%)

Fiscal Year

Minority-owned Firms Award Share (%)

Phase I

Phase II

Total

Phase I

Phase II

Total

1992

10.0

7.2

9.4

1992

7.4

5.0

6.9

1993

5.8

7.0

6.1

1993

5.2

5.6

5.3

1994

6.8

7.5

7.0

1994

8.2

10.4

8.6

1995

8.4

8.0

8.3

1995

5.5

6.1

5.7

1996

6.9

9.3

7.5

1996

4.8

5.2

4.9

1997

8.1

9.2

8.4

1997

5.1

4.4

4.9

1998

7.1

9.8

7.8

1998

3.9

6.4

4.5

1999

9.0

12.7

10.1

1999

6.3

4.0

5.6

2000

7.9

14.3

9.4

2000

2.9

6.4

3.7

2001

4.3

3.9

4.1

2001

2.1

3.7

2.6

2002

1.5

0.8

1.3

2002

0.3

0.8

0.5

2003

9.6

10.8

9.9

2003

3.8

2.8

3.5

2004

10.4

10.6

10.4

2004

4.0

3.4

3.9

2005

8.0

10.0

8.6

2005

4.0

2.9

3.7

2006

12.5

13.9

13.0

2006

5.6

3.3

4.7

SOURCE: National Institutes of Health.

Suggested Citation:"Appendix A: NIH SBIR Program Data." National Research Council. 2009. An Assessment of the SBIR Program at the National Institutes of Health. Washington, DC: The National Academies Press. doi: 10.17226/11964.
×

TABLE App-A-6 Woman- and Minority-owned Firms—Success Rates, 1992-2006 (percent)

Woman-owned Firms

Other Small Businesses

Minority-owned Firms

Fiscal Year

Success Rate (%)

Fiscal Year

Success Rate (%)

Fiscal Year

Success Rate (%)

Phase I

Phase II

All

Phase I

Phase II

All

Phase I

Phase II

Total

1992

22.3

18.9

21.7

1992

27.3

34.0

28.4

1992

19.7

30.4

20.8

1993

18.6

34.1

21.6

1993

25.8

44.0

29.0

1993

19.6

42.9

23.1

1994

12.0

26.3

13.6

1994

16.4

25.7

17.7

1994

13.9

34.1

16.2

1995

12.0

38.6

14.4

1995

18.0

34.2

20.4

1995

10.8

26.0

12.9

1996

10.0

28.1

12.5

1996

17.2

29.9

19.2

1996

8.2

29.0

10.1

1997

21.0

42.2

24.9

1997

26.5

45.0

30.1

1997

16.7

36.1

19.5

1998

22.7

47.9

27.3

1998

26.5

40.9

29.1

1998

18.9

46.9

24.0

1999

21.3

41.8

25.8

1999

25.3

42.1

28.5

1999

20.5

31.0

22.0

2000

19.7

34.5

23.2

2000

24.4

33.6

26.0

2000

12.8

37.8

17.3

2001

26.1

36.6

28.5

2001

27.7

44.1

31.4

2001

20.5

51.9

27.8

2002

14.3

10.3

13.3

2002

25.4

39.9

28.6

2002

7.3

20.0

10.7

2003

19.2

34.7

22.3

2003

22.2

34.6

24.7

2003

12.0

23.9

13.6

2004

16.3

25.9

18.2

2004

18.0

28.4

19.9

2004

9.9

18.8

11.2

2005

12.3

24.3

14.9

2005

16.4

28.9

18.9

2005

12.4

17.9

13.4

2006

16.9

36.2

21.4

2006

17.5

33.4

21.2

2006

14.5

27.7

16.5

SOURCE: National Institutes of Health

Suggested Citation:"Appendix A: NIH SBIR Program Data." National Research Council. 2009. An Assessment of the SBIR Program at the National Institutes of Health. Washington, DC: The National Academies Press. doi: 10.17226/11964.
×

TABLE App-A-7 Phase I by State—Compared with Scientists and Engineers Employed

 

Applications per 1,000 pop

State

AREA

Engineers

Scientists

Total Scientists and Engineers

All Employees

Scientists/Engineers/1,000 Employees

Applications

MA

90.2

2.4

AK

1

6,290

6,690

12,980

1,830,360

7.1

18

DC

57.2

12.8

AL

2

36,220

10,330

46,550

293,130

158.8

343

MD

54.5

12.0

AR

4

11,560

6,740

18,300

2,313,520

7.9

80

UT

33.1

11.9

AZ

5

56,460

14,790

71,250

1,125,830

63.3

528

NH

31.8

6.2

CA

6

319,420

147,100

466,520

14,534,620

32.1

8,929

VT

27.3

8.5

CO

8

53,000

25,260

78,260

2,110,640

37.1

1,053

CA

26.4

9.5

CT

9

37,290

16,970

54,260

1,633,350

33.2

708

DE

25.5

49.3

DC

10

13,350

20,520

33,870

408,270

83.0

327

CO

24.5

10.6

DE

11

6,090

6,380

12,470

603,130

20.7

200

VA

23.4

8.0

FL

12

113,390

46,750

160,140

7,330,880

21.8

1,034

WA

23.0

7.8

GA

13

55,680

23,280

78,960

3,806,550

20.7

472

OR

21.1

6.8

HI

15

7,920

4,710

12,630

564,850

22.4

170

IL

21.1

9.7

IA

16

15,880

9,780

25,660

574,270

44.7

161

CT

20.8

10.4

ID

17

13,670

9,100

22,770

5,719,070

4.0

77

AZ

19.8

2.6

IL

18

89,150

42,290

131,440

2,866,350

45.9

1,280

RI

19.3

15.0

IN

19

49,320

17,800

67,120

1,423,170

47.2

382

NM

17.3

11.2

KS

20

26,960

9,170

36,130

1,297,710

27.8

170

MN

16.8

8.2

KY

21

23,300

9,300

32,600

1,728,300

18.9

210

NJ

15.8

9.7

LA

22

28,580

13,050

41,630

1,861,000

22.4

201

WY

14.6

6.9

MA

23

73,160

40,340

113,500

595,120

190.7

5,728

MT

14.2

6.3

MD

24

52,070

34,340

86,410

2,458,140

35.2

2,886

HI

14.0

6.3

ME

25

9,800

4,250

14,050

3,125,930

4.5

154

IN

13.1

12.1

MI

26

134,090

30,900

164,990

4,294,310

38.4

939

PA

12.8

9.8

MN

27

55,180

26,780

81,960

2,602,230

31.5

826

IA

12.4

3.9

MO

28

35,600

18,550

54,150

1,095,450

49.4

331

NC

12.2

8.8

MS

29

15,120

6,740

21,860

2,630,780

8.3

55

ME

12.1

23.0

MT

30

5,620

7,530

13,150

402,930

32.6

128

SD

11.9

4.8

NC

31

51,390

38,010

89,400

883,450

101.2

984

Suggested Citation:"Appendix A: NIH SBIR Program Data." National Research Council. 2009. An Assessment of the SBIR Program at the National Institutes of Health. Washington, DC: The National Academies Press. doi: 10.17226/11964.
×

NY

11.9

7.2

ND

32

4,210

2,510

6,720

1,116,860

6.0

46

MO

11.6

4.8

NE

33

11,300

8,290

19,590

613,090

32.0

93

OH

11.3

8.7

NH

34

12,820

4,190

17,010

3,881,440

4.4

393

WI

10.9

4.5

NJ

35

57,810

39,250

97,060

755,620

128.5

1,328

MI

9.4

9.7

NM

36

22,060

12,880

34,940

8,248,470

4.2

314

TX

9.0

7.0

NV

37

14,910

6,980

21,890

3,722,700

5.9

110

AL

7.7

3.0

NY

38

105,190

74,280

179,470

318,520

563.4

2,253

ND

7.2

3.1

OH

39

96,320

33,550

129,870

5,308,970

24.5

1,286

TN

6.9

6.0

OK

40

21,360

11,490

32,850

1,421,270

23.1

128

FL

6.5

4.8

OR

41

31,790

17,890

49,680

1,556,470

31.9

721

KS

6.3

10.2

PA

42

88,560

47,440

136,000

5,507,880

24.7

1,570

GA

5.8

7.8

RI

44

8,150

4,310

12,460

480,420

25.9

202

NV

5.5

8.7

SC

45

36,360

10,830

47,190

1,772,760

26.6

144

NE

5.4

6.6

SD

46

3,960

3,370

7,330

368,100

19.9

90

KY

5.2

4.6

TN

47

35,600

13,660

49,260

2,634,450

18.7

390

LA

4.5

6.6

TX

48

198,990

69,090

268,080

9,299,360

28.8

1,871

OK

3.7

5.7

UT

49

19,700

12,150

31,850

1,059,720

30.1

739

SC

3.6

6.0

VA

50

75,070

33,620

108,690

293,650

370.1

1,657

AK

2.9

6.9

VT

51

5,780

3,080

8,860

3,451,890

2.6

166

WV

1.9

9.7

WA

53

66,240

40,040

106,280

2,583,080

41.1

1,355

AR

1.6

8.1

WI

54

47,940

25,000

72,940

685,110

106.5

584

MS

1.0

7.3

WV

55

9,470

5,970

15,440

2,689,160

5.7

34

ID

0.6

9.7

WY

56

3,640

4,100

7,740

245,050

31.6

72

SOURCE: National Institutes of Health.

Suggested Citation:"Appendix A: NIH SBIR Program Data." National Research Council. 2009. An Assessment of the SBIR Program at the National Institutes of Health. Washington, DC: The National Academies Press. doi: 10.17226/11964.
×

TABLE App-A-8 Phase I—New Applicants and New Winners, 2000-2005

Number of “New” organizations by Fiscal Year, Based on Funded Competing R43, U43 SBIR Phase 1 Grants

Baseline 1986 (program started in 1983, but recovering data from the mainframe files is difficult)

Calculated by using the year of first SBIR award post baseline

Source: impacii irdb pubfiles (1986 thru 2005)

Fiscal Year

Number of “New” Winners

Number of “New” Applicants

All Applicants (#)

All Winners (#)

“New” Winners (%)

“New” Applicants (%)

Success Rate of New Applicants (%)

Success Rate of Previous Winners (%)

2000

306

1,263

2,006

649

47.1

63.0

24.2

46.2

2001

240

963

1,660

603

39.8

58.0

24.9

52.1

2002

274

1,198

1,937

650

42.2

61.8

22.9

50.9

2003

305

1,499

2,353

712

42.8

63.7

20.3

47.7

2004

294

1,703

2,680

705

41.7

63.5

17.3

42.1

2005

211

1,493

2,449

589

35.8

61.0

14.1

39.5

NOTE New is based on organizations with no previous SBIR support; however, these organizations may have submitted more than one application in previous years.

SOURCE: National Institutes of Health.

Suggested Citation:"Appendix A: NIH SBIR Program Data." National Research Council. 2009. An Assessment of the SBIR Program at the National Institutes of Health. Washington, DC: The National Academies Press. doi: 10.17226/11964.
×

TABLE App-A-9 Phase I Awards—By State, 1992-2005

State

Number of Phase I State Awards by Fiscal Year

Grand Total

Percent of Total

1992

1993

1994

1995

1996

1997

1998

1999

2000

2001

2002

2003

2004

2005

AK

 

 

 

 

 

 

 

 

 

 

 

2

 

1

3

0.0

AL

5

11

6

4

7

5

6

10

8

11

9

8

6

4

100

0.8

AR

2

 

 

 

 

1

 

3

1

2

1

3

4

5

22

0.2

AZ

14

11

2

10

8

7

10

11

11

15

26

14

12

8

159

1.2

CA

110

114

133

144

117

153

136

201

226

240

238

275

232

178

2,497

19.5

CO

8

14

8

12

17

22

20

19

36

22

31

36

34

27

306

2.4

CT

17

11

13

13

9

19

12

15

13

13

21

26

19

11

212

1.7

DC

4

6

6

6

2

3

6

7

11

11

16

10

5

4

97

0.8

DE

 

2

2

2

2

5

1

6

8

7

4

7

6

4

56

0.4

FL

10

11

9

14

11

18

8

11

30

18

23

32

20

16

231

1.8

GA

5

3

3

6

8

5

4

4

16

12

12

14

19

6

117

0.9

HI

8

5

4

3

3

3

3

2

3

6

3

1

1

1

46

0.4

IA

 

1

 

 

1

1

1

3

3

4

5

9

4

2

34

0.3

ID

1

1

 

 

 

 

1

 

2

4

1

1

1

1

13

0.1

IL

13

21

15

22

11

25

22

19

36

35

28

31

22

29

329

2.6

IN

5

5

5

6

5

5

3

7

7

9

7

14

11

12

101

0.8

KS

1

2

 

1

1

 

 

4

2

4

5

6

4

1

31

0.2

KY

2

3

2

1

2

4

1

3

9

13

10

2

4

4

60

0.5

LA

3

2

3

1

 

2

 

 

5

2

3

3

2

1

27

0.2

MA

91

114

105

100

105

111

120

175

212

193

189

170

152

106

1,943

15.2

MD

68

58

52

54

24

60

38

67

63

84

77

114

85

58

902

7.1

ME

2

2

1

6

2

 

1

3

3

2

5

3

2

2

34

0.3

MI

15

18

13

17

10

9

22

20

19

35

24

31

27

24

284

2.2

MN

11

13

10

21

11

12

16

7

17

21

24

28

18

19

228

1.8

MO

6

8

2

1

3

3

4

5

6

8

12

12

10

8

88

0.7

MS

 

 

1

1

1

1

 

2

1

1

2

2

1

 

13

0.1

MT

 

 

2

 

1

 

3

2

3

4

3

1

4

2

25

0.2

Suggested Citation:"Appendix A: NIH SBIR Program Data." National Research Council. 2009. An Assessment of the SBIR Program at the National Institutes of Health. Washington, DC: The National Academies Press. doi: 10.17226/11964.
×

State

Number of Phase I Awards by Fiscal Year

Grand Total

Percent of Total

1992

1993

1994

1995

1996

1997

1998

1999

2000

2001

2002

2003

2004

2005

NC

22

10

15

10

14

21

23

21

32

37

39

35

39

28

346

2.7

ND

1

 

 

 

 

 

 

 

 

1

2

1

3

 

8

0.1

NE

1

3

1

1

 

4

2

1

3

3

4

3

3

5

34

0.3

NH

4

7

6

3

8

13

4

6

12

18

18

20

7

3

129

1.0

NJ

12

20

14

15

21

18

17

27

34

34

42

33

29

23

339

2.7

NM

7

2

1

3

1

4

2

8

8

10

8

12

11

4

81

0.6

NV

 

 

 

 

 

3

1

 

1

2

3

5

 

3

18

0.1

NY

47

38

32

31

25

28

42

43

62

54

71

53

52

45

623

4.9

OH

17

19

12

19

12

26

34

26

39

47

47

50

37

35

420

3.3

OK

4

3

 

2

2

 

3

2

2

3

7

5

4

5

42

0.3

OR

9

11

13

19

16

16

14

18

32

27

34

29

19

12

269

2.1

PA

22

19

14

24

21

27

28

24

46

57

56

49

47

41

475

3.7

PR

 

 

 

 

 

 

1

1

1

 

 

 

 

 

3

0.0

RI

 

 

1

1

 

 

1

3

8

9

10

7

10

8

58

0.5

SC

 

 

 

 

1

1

3

2

3

6

12

8

3

2

41

0.3

SD

 

 

 

1

1

1

1

2

 

2

3

1

1

 

13

0.1

TN

3

3

4

3

2

8

3

2

6

9

8

9

4

4

68

0.5

TX

29

25

23

24

22

35

24

39

64

43

46

65

55

37

531

4.2

UT

14

11

10

10

7

14

16

14

23

25

23

11

17

8

203

1.6

VA

20

23

21

21

14

29

23

22

36

50

37

57

30

20

403

3.2

VT

3

6

3

3

1

1

 

2

3

2

2

8

4

2

40

0.3

WA

16

18

17

22

24

30

28

44

48

47

59

48

37

28

466

3.6

WI

4

5

12

9

7

10

15

15

16

29

25

27

18

15

207

1.6

WV

 

 

 

 

 

 

 

 

1

1

 

 

 

 

2

0.0

WY

 

 

 

 

 

1

2

3

2

1

4

2

 

 

15

0.1

Grand Total

636

659

596

666

560

764

725

931

1,233

1,293

1,339

1,393

1,135

862

12,792

100.0

SOURCE: U.S. Small Business Administration, Tech-Net Database.

Suggested Citation:"Appendix A: NIH SBIR Program Data." National Research Council. 2009. An Assessment of the SBIR Program at the National Institutes of Health. Washington, DC: The National Academies Press. doi: 10.17226/11964.
×

TABLE App-A-10 Resubmission Rates—Phases I and II, 1992-2004

Phase I

Fiscal Year

All Applications (#)

Resubmissions (#)

Resubmission as Percent of Applications

Total Funded (#)

1st-time Winners (#)

Funded on Resubmission (#)

Not Funded (#)

1st-time Success Rate (%)

Resubmission Success Rate (%)

1992

1,980

334

23.2

540

442

98

1,440

26.9

29.3

1993

2,293

312

18.4

593

514

79

1,700

25.9

25.3

1994

3,222

427

15.9

530

473

57

2,692

16.9

13.3

1995

3,448

655

23.2

621

467

154

2,827

16.7

23.5

1996

3,047

657

26.0

523

395

128

2,524

16.5

19.5

1997

2,788

607

29.7

742

526

216

2,046

24.1

35.6

1998

2,675

514

26.2

716

581

135

1,959

26.9

26.3

1999

3,413

612

24.4

906

761

145

2,507

27.2

23.7

2000

3,865

786

27.1

969

746

223

2,896

24.2

28.4

2001

3,186

760

33.4

911

658

253

2,275

27.1

33.3

2002

3,662

636

23.4

945

773

172

2,717

25.5

27.0

2003

4,716

864

21.6

710

472

238

4,006

12.3

27.5

2004

5,731

1,167

24.8

1,028

767

261

4,703

16.8

22.4

Suggested Citation:"Appendix A: NIH SBIR Program Data." National Research Council. 2009. An Assessment of the SBIR Program at the National Institutes of Health. Washington, DC: The National Academies Press. doi: 10.17226/11964.
×

Phase II

Fiscal Year

All Applications (#)

Resubmissions (#)

Resubmission as Percent of Applications

Total Funded (#)

1st-time Winners(#)

Funded on Resubmission (#)

Not Funded (#)

1st-time Success Rate (%)

Resubmission Success Rate (%)

1992

409

103

25.2

137

107

30

272

35.0

29.1

1993

489

147

30.1

215

160

55

274

46.8

37.4

1994

522

138

26.4

131

110

21

391

28.6

15.2

1995

619

202

32.6

210

162

48

409

38.8

23.8

1996

575

204

35.5

173

124

49

402

33.4

24.0

1997

612

211

34.5

280

191

89

332

47.6

42.2

1998

504

141

28.0

237

193

44

267

53.2

31.2

1999

627

149

23.8

289

231

58

338

48.3

38.9

2000

653

197

30.2

267

206

61

386

45.2

31.0

2001

732

242

33.1

381

284

97

351

58.0

40.1

2002

772

242

31.3

358

269

89

414

50.8

36.8

2003

830

249

30.0

349

264

85

481

45.4

34.1

2004

908

287

31.6

302

223

79

606

35.9

27.5

SOURCE: National Institutes of Health.

Suggested Citation:"Appendix A: NIH SBIR Program Data." National Research Council. 2009. An Assessment of the SBIR Program at the National Institutes of Health. Washington, DC: The National Academies Press. doi: 10.17226/11964.
×

TABLE App-A-11 Phase I, Year One Awards at NIH, 1992-2005

Fiscal Year

Number of Awards

Total Amount ($)

Average Amount ($)

1992

541

26,616,441

49,199

1993

594

29,560,122

49,765

1994

530

39,249,711

74,056

1995

624

59,005,464

94,560

1996

525

50,936,972

97,023

1997

743

72,528,667

97,616

1998

717

70,077,801

97,738

1999

908

96,125,835

105,865

2000

986

117,779,337

119,452

2001

940

120,072,266

127,736

2002

1,001

137,504,731

137,367

2003

1,137

168,520,060

148,215

2004

1,150

187,091,805

162,689

2005

937

160,982,684

171,806

SOURCE: National Institutes of Health, NRC calculation.

FIGURE App-A-1 Phase I median award size, 1992-2003.

FIGURE App-A-1 Phase I median award size, 1992-2003.

SOURCE: National Institutes of Health, NRC calculation.

Suggested Citation:"Appendix A: NIH SBIR Program Data." National Research Council. 2009. An Assessment of the SBIR Program at the National Institutes of Health. Washington, DC: The National Academies Press. doi: 10.17226/11964.
×

TABLE App-A-12 Oversized SBIR Phase I Awards, 1992-2005

Fiscal Year

$0-$100K (%)

$>100K-$120K (%)

$>120K-$150K (%)

$>150K-$175K (%)

$>175K-$200K (%)

>$200K (%)

1992

100.0

0.0

0.0

0.0

0.0

0.0

1993

100.0

0.0

0.0

0.0

0.0

0.0

1994

100.0

0.0

0.0

0.0

0.0

0.0

1995

99.7

0.3

0.0

0.0

0.0

0.0

1996

99.4

0.6

0.0

0.0

0.0

0.0

1997

99.7

0.1

0.1

0.0

0.0

0.0

1998

95.4

3.5

1.2

0.0

0.0

0.0

1999

70.8

16.6

7.0

2.5

0.1

2.9

2000

62.1

16.4

11.1

2.0

2.2

6.3

2001

53.8

13.9

13.5

5.1

5.1

8.6

2002

51.8

13.5

12.2

5.8

6.6

10.1

2003

48.0

13.9

12.7

4.1

4.6

16.7

2004

43.4

10.9

14.2

6.0

6.4

19.1

2005

40.5

10.5

15.6

7.6

7.8

18.0

SOURCE: National Institutes of Health.

Suggested Citation:"Appendix A: NIH SBIR Program Data." National Research Council. 2009. An Assessment of the SBIR Program at the National Institutes of Health. Washington, DC: The National Academies Press. doi: 10.17226/11964.
×

TABLE App-A-13 Phase I Awards by States—Per 1,000 Life and Physical Scientists

 

Life & Physical Scientists, 2003

NIH Phase I Awards, 2003

NIH Phase I Awards per 1,000 Life & Physical Scientists, 2003

New Hampshire

1,480

14.0

9.5

Vermont

850

6.0

7.1

Massachusetts

20,380

140.0

6.9

Maryland

17,910

90.0

5.0

Oregon

5,870

23.0

3.9

Connecticut

5,670

22.0

3.9

California

64,390

248.0

3.9

Virginia

13,030

40.0

3.1

Ohio

15,100

45.0

3.0

Iowa

3,130

9.0

2.9

Colorado

11,710

33.0

2.8

Indiana

4,070

11.0

2.7

Rhode Island

1,580

4.0

2.5

Michigan

9,390

23.0

2.4

Arizona

5,580

13.0

2.3

Nevada

2,510

5.0

2.0

Wyoming

1,510

3

2.0

Delaware

2,020

4.0

2.0

Minnesota

11,200

22.0

2.0

Washington

16,940

33.0

1.9

New Mexico

3,200

6.0

1.9

Wisconsin

11,220

21.0

1.9

New Jersey

17,530

32.0

1.8

Utah

5,060

9.0

1.8

South Carolina

4,610

8.0

1.7

Maine

1,830

3.0

1.6

Pennsylvania

25,080

41.0

1.6

District of Columbia

5,210

8.0

1.5

Oklahoma

3,350

5.0

1.5

North Dakota

1,420

2.0

1.4

New York

30,330

41.0

1.4

North Carolina

17,770

24.0

1.4

Missouri

9,240

12.0

1.3

Kansas

3,910

5.0

1.3

Florida

19,440

24.0

1.2

Alabama

5,170

6.0

1.2

Texas

42,440

49.0

1.2

Illinois

18,300

21.0

1.1

Arkansas

2,700

3.0

1.1

Louisiana

5,540

5.0

0.9

Nebraska

3,920

3.0

0.8

Kentucky

2,660

2.0

0.8

Alaska

2,800

2.0

0.7

South Dakota

1,420

1.0

0.7

Suggested Citation:"Appendix A: NIH SBIR Program Data." National Research Council. 2009. An Assessment of the SBIR Program at the National Institutes of Health. Washington, DC: The National Academies Press. doi: 10.17226/11964.
×

 

Life & Physical Scientists, 2003

NIH Phase I Awards, 2003

NIH Phase I Awards per 1,000 Life & Physical Scientists, 2003

Georgia

11,410

8.0

0.7

Tennessee

7,130

4.0

0.6

Hawaii

1,790

1.0

0.6

Montana

2,790

1.0

0.4

Idaho

3,100

1.0

0.3

Mississippi

3,650

1.0

0.3

West Virginia

2,510

0.0

0.0

Average

 

 

3.2

SOURCE: National Institutes of Health; National Science Board, Science and Engineering Indicators 2005, Arlington, VA: National Science Foundation, 2005.

TABLE App-A-14 Top 20 Zip Codes, 1992-2003

Zip Code

State

Total Number of Grants

92121

CA

311

02139

MA

143

94043

CA

114

02472

MA

99

01801

MA

92

01915

MA

73

20850

MD

73

20877

MD

64

97403

OR

60

84108

UT

57

02138

MA

57

53711

WI

52

98104

WA

50

92037

CA

47

77840

TX

46

94545

CA

45

98109

WA

44

92008

CA

44

27713

NC

41

02464

MA

40

02142

MA

39

 

 

1,591

SOURCE: National Institutes of Health.

Suggested Citation:"Appendix A: NIH SBIR Program Data." National Research Council. 2009. An Assessment of the SBIR Program at the National Institutes of Health. Washington, DC: The National Academies Press. doi: 10.17226/11964.
×
FIGURE App-A-2 Phase I awards by zip in Massacussetts.

FIGURE App-A-2 Phase I awards by zip in Massacussetts.

Distribution of Phase I awards in Massachusetts 1992-2002 by zip code

SOURCE: National Institutes of Health.

Suggested Citation:"Appendix A: NIH SBIR Program Data." National Research Council. 2009. An Assessment of the SBIR Program at the National Institutes of Health. Washington, DC: The National Academies Press. doi: 10.17226/11964.
×

TABLE App-A-15 Phase I Awards by IC, 1992-2002

Funding IC

Number of Awards

1992

1993

1994

1995

1996

1997

1998

1999

2000

2001

2002

Total

AA

4

7

3

7

4

12

4

14

15

9

11

90

AG

12

14

28

16

5

34

26

29

34

37

26

261

AI

63

73

49

74

70

100

83

91

99

104

122

928

AR

5

16

17

26

29

25

20

27

22

27

14

228

AT

 

 

 

 

 

 

 

2

6

7

7

22

CA

160

157

114

95

80

154

138

192

181

187

212

1,670

DA

13

9

22

24

19

13

14

32

30

27

20

223

DC

6

10

12

8

5

12

8

20

21

18

9

129

DE

6

8

6

14

7

6

14

8

31

34

12

146

DK

16

22

36

49

39

50

40

70

82

65

67

536

EB

 

 

 

 

 

 

 

 

 

 

17

17

ES

8

8

8

9

10

8

9

11

23

28

30

152

EY

16

14

25

28

27

18

18

18

19

19

29

231

GM

42

63

48

42

53

68

74

88

79

80

76

713

HD

31

52

24

27

35

42

32

37

51

30

41

402

HG

6

5

4

5

5

8

17

17

9

8

22

106

HL

68

51

56

103

79

83

72

109

133

112

85

951

LM

2

3

2

 

 

3

6

4

4

1

2

27

MH

17

24

20

33

21

36

34

41

31

36

42

335

NR

4

7

1

6

1

3

6

5

5

2

2

42

NS

25

23

35

40

19

31

45

51

50

42

50

411

RR

36

27

20

13

14

33

40

39

41

36

33

332

Shared

 

 

 

2

1

3

16

1

3

2

16

44

Total

540

593

530

621

523

742

716

906

969

911

945

7,996

Suggested Citation:"Appendix A: NIH SBIR Program Data." National Research Council. 2009. An Assessment of the SBIR Program at the National Institutes of Health. Washington, DC: The National Academies Press. doi: 10.17226/11964.
×

Funding IC

Percentage of Awards

1992

1993

1994

1995

1996

1997

1998

1999

2000

2001

2002

Total

AA

0.7

1.2

0.6

1.1

0.8

1.6

0.6

1.5

1.5

1.0

1.2

1.1

AG

2.2

2.4

5.3

2.6

1.0

4.6

3.6

3.2

3.5

4.1

2.8

3.3

AI

11.7

12.3

9.2

11.9

13.4

13.5

11.6

10.0

10.2

11.4

12.9

11.6

AR

0.9

2.7

3.2

4.2

5.5

3.4

2.8

3.0

2.3

3.0

1.5

2.9

AT

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.2

0.6

0.8

0.7

0.3

CA

29.6

26.5

21.5

15.3

15.3

20.8

19.3

21.2

18.7

20.5

22.4

20.9

DA

2.4

1.5

4.2

3.9

3.6

1.8

2.0

3.5

3.1

3.0

2.1

2.8

DC

1.1

1.7

2.3

1.3

1.0

1.6

1.1

2.2

2.2

2.0

1.0

1.6

DE

1.1

1.3

1.1

2.3

1.3

0.8

2.0

0.9

3.2

3.7

1.3

1.8

DK

3.0

3.7

6.8

7.9

7.5

6.7

5.6

7.7

8.5

7.1

7.1

6.7

EB

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

1.8

0.2

ES

1.5

1.3

1.5

1.4

1.9

1.1

1.3

1.2

2.4

3.1

3.2

1.9

EY

3.0

2.4

4.7

4.5

5.2

2.4

2.5

2.0

2.0

2.1

3.1

2.9

GM

7.8

10.6

9.1

6.8

10.1

9.2

10.3

9.7

8.2

8.8

8.0

8.9

HD

5.7

8.8

4.5

4.3

6.7

5.7

4.5

4.1

5.3

3.3

4.3

5.0

HG

1.1

0.8

0.8

0.8

1.0

1.1

2.4

1.9

0.9

0.9

2.3

1.3

HL

12.6

8.6

10.6

16.6

15.1

11.2

10.1

12.0

13.7

12.3

9.0

11.9

LM

0.4

0.5

0.4

0.0

0.0

0.4

0.8

0.4

0.4

0.1

0.2

0.3

MH

3.1

4.0

3.8

5.3

4.0

4.9

4.7

4.5

3.2

4.0

4.4

4.2

NR

0.7

1.2

0.2

1.0

0.2

0.4

0.8

0.6

0.5

0.2

0.2

0.5

NS

4.6

3.9

6.6

6.4

3.6

4.2

6.3

5.6

5.2

4.6

5.3

5.1

RR

6.7

4.6

3.8

2.1

2.7

4.4

5.6

4.3

4.2

4.0

3.5

4.2

Shared

0.0

0.0

0.0

0.3

0.2

0.4

2.2

0.1

0.3

0.2

1.7

0.6

Total

100.0

100.0

100.0

100.0

100.0

100.0

100.0

100.0

100.0

100.0

100.0

100.0

Suggested Citation:"Appendix A: NIH SBIR Program Data." National Research Council. 2009. An Assessment of the SBIR Program at the National Institutes of Health. Washington, DC: The National Academies Press. doi: 10.17226/11964.
×

Shared awards:

1992

1993

1994

1995

1996

1997

1998

1999

2000

2001

2002

AA, RR, RR

 

 

 

 

 

 

 

 

 

 

6

AG, DA, DA

 

 

 

 

 

 

 

 

 

1

 

AG, HD, HD

 

 

 

 

 

 

 

 

 

1

 

AR, CA, CA

 

 

 

 

 

 

2

 

 

 

 

AR, HD, HD

 

 

 

 

 

1

 

 

 

 

 

AR, NR, NR

 

 

 

1

 

 

 

 

 

 

 

AT, OD, OD

 

 

 

 

 

 

 

 

 

 

3

CA, DK, DK

 

 

 

 

 

 

 

 

1

 

 

CA, HD, HD

 

 

 

 

 

 

1

 

 

 

 

CA, MD, MD

 

 

 

 

 

 

 

 

 

 

1

CA, RR, RR

 

 

 

 

 

1

 

 

 

 

 

DC, MD, MD

 

 

 

 

 

 

 

 

 

 

5

DC, MH, MH

 

 

 

 

1

 

 

 

 

 

 

DC, NR, NR

 

 

 

 

 

 

 

1

 

 

 

GM, GM

 

 

 

1

 

 

 

 

 

 

 

GM, LM, LM

 

 

 

 

 

1

 

 

 

 

 

HD, HD

 

 

 

 

 

 

9

 

 

 

 

HD, MH, MH

 

 

 

 

 

 

3

 

 

 

 

HD, NR, NR

 

 

 

 

 

 

1

 

 

 

 

MH, MH

 

 

 

 

 

 

 

 

2

 

1

Total

 

 

 

2

1

3

16

1

3

2

16

SOURCE: National Institutes of Health.

Suggested Citation:"Appendix A: NIH SBIR Program Data." National Research Council. 2009. An Assessment of the SBIR Program at the National Institutes of Health. Washington, DC: The National Academies Press. doi: 10.17226/11964.
×

TABLE App-A-16 New Phase I Awards Made in Response to an RFA, 1992-2005

Fiscal Year

PHASE

Total Number of SBIR Awards (Parent Solicitation and Special PA/RFAs)

Total Amount of SBIR Dollars Awarded (Parent Solicitation and Special PA/RFAs)

Number of RFA SBIR Awards

Amount of RFA SBIR Dollars Awarded

RFA—Percent of All Awards

RFA—Percent of All Award Dollars

1992

Phase I

540

26,571,593

0

0

0.0

0.0

1993

Phase I

591

29,447,790

0

0

0.0

0.0

1994

Phase I

527

39,143,156

37

2,779,027

7.0

7.1

1995

Phase I

619

58,441,688

6

470,612

1.0

0.8

1996

Phase I

523

50,634,759

3

300,000

0.6

0.6

1997

Phase I

741

72,325,975

0

0

0.0

0.0

1998

Phase I

702

69,368,224

1

98,525

0.1

0.1

1999

Phase I

874

94,944,070

5

1,283,242

0.6

1.4

2000

Phase I

944

113,276,949

12

2,976,638

1.3

2.6

2001

Phase I

884

112,650,165

10

2,417,588

1.1

2.1

2002

Phase I

930

124,423,577

65

11,586,853

7.0

9.3

2003

Phase I

1,042

150,880,637

15

3,145,579

1.4

2.1

2004

Phase I

1,023

158,499,201

15

4,595,326

1.5

2.9

2005

Phase I

806

126,216,067

20

3,044,462

2.5

2.4

SOURCE: National Institutes of Health.

Suggested Citation:"Appendix A: NIH SBIR Program Data." National Research Council. 2009. An Assessment of the SBIR Program at the National Institutes of Health. Washington, DC: The National Academies Press. doi: 10.17226/11964.
×

TABLE App-A-17 New Phase I Awards Made in Response to Program Announcements, 1992-2005 (PAs)

Fiscal Year

PHASE

Total Number of SBIR Awards (Parent Solicitation and Special PA/RFAs)

Total Amount of SBIR Dollars Awarded (Parent Solicitation and Special PA/RFAs)

Number of PA SBIR Awards

Amount of PA SBIR Dollars Awarded

Percent of Awards

Percent of Dollars

1992

Phase I

540

26,571,593

0

0

0.0

0.0

1993

Phase I

591

29,447,790

0

0

0.0

0.0

1994

Phase I

527

39,143,156

0

0

0.0

0.0

1995

Phase I

619

58,441,688

0

0

0.0

0.0

1996

Phase I

523

50,634,759

0

0

0.0

0.0

1997

Phase I

741

72,325,975

0

0

0.0

0.0

1998

Phase I

702

69,368,224

1

106,906

0.1

0.2

1999

Phase I

874

94,944,070

33

5,470,073

3.8

5.8

2000

Phase I

944

113,276,949

42

9,826,643

4.4

8.7

2001

Phase I

884

112,650,165

70

13,256,620

7.9

11.8

2002

Phase I

930

124,423,577

120

23,269,261

12.9

18.7

2003

Phase I

1,042

150,880,637

194

41,577,617

18.6

27.6

2004

Phase I

1,023

158,499,201

215

48,889,961

21.0

30.8

2005

Phase I

806

126,216,067

160

34,525,730

19.9

27.4

SOURCE: National Institutes of Health.

Suggested Citation:"Appendix A: NIH SBIR Program Data." National Research Council. 2009. An Assessment of the SBIR Program at the National Institutes of Health. Washington, DC: The National Academies Press. doi: 10.17226/11964.
×

TABLE App-A-18 Phase I Awards—By Company, 1992-2003

Top 20 Phase I winners 1992-2003

Organization

Number of Awards

PANORAMA RESEARCH, INC.

69

INOTEK PHARMACEUTICALS CORPORATION

63

RADIATION MONITORING DEVICES, INC.

56

LYNNTECH, INC.

51

INFLEXXION, INC.

44

OREGON CENTER FOR APPLIED SCIENCE

44

NEW ENGLAND RESEARCH INSTITUTES, INC.

42

CREARE, INC.

40

INSIGHTFUL CORPORATION

40

HAWAII BIOTECH, INC.

38

PHYSICAL OPTICS CORPORATION

33

BIOMEC, INC.

30

SURMODICS, INC.

30

BIOTEK, INC.

29

SPIRE CORPORATION

28

ONE CELL SYSTEMS, INC.

27

COMPACT MEMBRANE SYSTEMS, INC.

26

OSI PHARMACEUTICALS, INC.

26

PERSONAL IMPROVEMENT COMPUTER SYSTEMS

25

PHYSICAL SCIENCES, INC.

25

Total

766

SOURCE: National Institutes of Health.

TABLE App-A-19 Phase I—Supplementary Awards, 1992-2003

Fiscal Year

1993

1994

1995

1998

1999

2000

2001

2002

2003

Count

2

3

2

10

23

21

20

12

10

Average ($)

16,238

9,328

17,987

43,013

35,894

36,210

45,311

57,363

78,782

Maximum ($)

25,000

15,000

26,331

98,000

98,000

105,853

173,059

287,606

151,607

Minimum ($)

7,475

5,998

9,643

3,400

400

9,813

15,000

12,600

4,029

Sum ($)

32,475

27,984

35,974

430,129

825,553

760,416

906,214

688,356

787,821

SOURCE: National Institutes of Health.

Suggested Citation:"Appendix A: NIH SBIR Program Data." National Research Council. 2009. An Assessment of the SBIR Program at the National Institutes of Health. Washington, DC: The National Academies Press. doi: 10.17226/11964.
×

TABLE App-A-20 Phase I Awards—Year Two of Support, 1992-2003

Fiscal Year

1992

1993

1995

1996

1997

1998

1999

2000

2001

2002

2003

Count

1

1

3

2

1

1

2

17

29

56

81

Average ($)

44,848

49,957

78,618

57,718

99,944

100,009

55,858

203,928

216,888

214,773

195,558

Minimum ($)

44,848

49,957

100,000

85,435

99,944

100,009

101,715

344,294

387,813

307,200

376,150

Maximum ($)

44,848

49,957

49,413

30,000

99,944

100,009

10,000

71,238

65,428

15,600

49,930

Sum ($)

44,848

49,957

235,855

115,435

99,944

100,009

111,715

3,466,776

6,289,766

12,027,313

15,840,190

SOURCE: National Institutes of Health.

Suggested Citation:"Appendix A: NIH SBIR Program Data." National Research Council. 2009. An Assessment of the SBIR Program at the National Institutes of Health. Washington, DC: The National Academies Press. doi: 10.17226/11964.
×

TABLE App-A-21 Phase II—Year One Awards, 1992-2005

Fiscal Year

Number of Awards

Total Dollars

Average Award Size ($)

1992

278

64,634,293

232,497

1993

360

82,904,116

230,289

1994

351

82,130,205

233,989

1995

370

106,153,197

286,901

1996

390

124,699,140

319,741

1997

468

163,756,939

349,908

1998

541

182,404,280

337,161

1999

539

199,696,146

370,494

2000

587

223,656,320

381,016

2001

683

274,218,417

401,491

2002

797

330,503,121

414,684

2003

788

343,893,012

436,412

2004

792

362,710,289

457,968

2005

774

396,764,618

512,616

SOURCE: National Institutes of Health.

TABLE App-A-22 Phase II—Requests for Applications (RFAs), 1992-2005

Fiscal Year

PHASE

Total Number of SBIR Awards (Parent Solicitation and Special PA/RFAs)

Total Amount of SBIR Dollars Awarded (Parent Solicitation and Special PA/RFAs)

Number of RFA SBIR Awards

Amount of RFA SBIR Dollars Awarded

RFA—Percent of All Awards

RFA—Percent of All Award Dollars

1992

Phase II

139

34,653,136

0

0

0.0

0.0

1993

Phase II

215

52,537,980

0

0

0.0

0.0

1994

Phase II

134

36,697,824

0

0

0.0

0.0

1995

Phase II

212

73,059,839

0

0

0.0

0.0

1996

Phase II

172

60,806,200

0

0

0.0

0.0

1997

Phase II

279

104,817,711

0

0

0.0

0.0

1998

Phase II

224

85,283,655

0

0

0.0

0.0

1999

Phase II

278

114,811,423

1

507,041

0.4

0.4

2000

Phase II

231

102,407,911

0

0

0.0

0.0

2001

Phase II

343

148,866,724

0

0

0.0

0.0

2002

Phase II

336

154,925,573

0

0

0.0

0.0

2003

Phase II

327

156,101,955

0

0

0.0

0.0

2004

Phase II

298

153,544,979

5

2,594,326

1.7

1.7

2005

Phase II

312

163,695,822

5

2,659,999

1.6

1.6

SOURCE: National Institutes of Health.

Suggested Citation:"Appendix A: NIH SBIR Program Data." National Research Council. 2009. An Assessment of the SBIR Program at the National Institutes of Health. Washington, DC: The National Academies Press. doi: 10.17226/11964.
×

TABLE App-A-23 Phase II—Program Announcements (PAs)—New Awards, 1992-2005

Fiscal Year

PHASE

Total Number of SBIR Awards (Parent Solicitation and Special PA/RFAs)

Total Amount of SBIR Dollars Awarded (Parent Solicitation and Special PA/RFAs)

Number of PA SBIR Awards

Amount of PA SBIR Dollars Awarded

PA—Percent of All Awards

PA—Percent of All Award Dollars

1992

Phase II

139

34,653,136

0

0

0.0

0.0

1993

Phase II

215

52,537,980

0

0

0.0

0.0

1994

Phase II

134

36,697,824

0

0

0.0

0.0

1995

Phase II

212

73,059,839

0

0

0.0

0.0

1996

Phase II

172

60,806,200

0

0

0.0

0.0

1997

Phase II

279

104,817,711

0

0

0.0

0.0

1998

Phase II

224

85,283,655

0

0

0.0

0.0

1999

Phase II

278

114,811,423

2

1,256,508

0.7

1.1

2000

Phase II

231

102,407,911

1

370,000

0.4

0.4

2001

Phase II

343

148,866,724

8

4,398,827

2.3

3.0

2002

Phase II

336

154,925,573

8

4,980,270

2.4

3.2

2003

Phase II

327

156,101,955

30

17,637,373

9.2

11.3

2004

Phase II

298

153,544,979

32

23,569,833

10.7

15.4

2005

Phase II

312

163,695,822

43

30,719,886

13.8

18.8

SOURCE: National Institutes of Health.

Suggested Citation:"Appendix A: NIH SBIR Program Data." National Research Council. 2009. An Assessment of the SBIR Program at the National Institutes of Health. Washington, DC: The National Academies Press. doi: 10.17226/11964.
×

TABLE App-A-24 Phase II Extra-large Awards, 1992-2005

Fiscal Year

NIH Phase II SBIR Awards Over 375K

PHASE

Total Number Funded

Year Two

Year Three

Year Four

Year Five

1992

Phase II

139

1

0.7%

0

0.0%

0

0.0%

0

0.0%

1993

Phase II

215

5

2.3%

0

0.0%

0

0.0%

0

0.0%

1994

Phase II

134

7

5.2%

1

0.7%

0

0.0%

0

0.0%

1995

Phase II

212

70

33.0%

0

0.0%

0

0.0%

0

0.0%

1996

Phase II

172

68

39.5%

0

0.0%

0

0.0%

0

0.0%

1997

Phase II

279

131

47.0%

1

0.4%

0

0.0%

0

0.0%

1998

Phase II

224

106

47.3%

0

0.0%

0

0.0%

0

0.0%

1999

Phase II

278

169

60.8%

2

0.7%

0

0.0%

0

0.0%

2000

Phase II

231

155

67.1%

1

0.4%

0

0.0%

0

0.0%

2001

Phase II

343

240

70.0%

1

0.3%

0

0.0%

0

0.0%

2002

Phase II

336

238

70.8%

2

0.6%

0

0.0%

0

0.0%

2003

Phase II

327

224

68.5%

8

2.4%

0

0.0%

1

0.3%

2004

Phase II

298

194

65.1%

15

5.0%

2

0.7%

1

0.3%

2005

Phase II

312

205

65.7%

15

4.8%

14

4.5%

2

0.6%

Fiscal Year

NIH Phase II SBIR Awards Over 500K

PHASE

Total Number Funded

Year Two

Year Three

Year Four

Year Five

1992

Phase II

139

0

0.0%

0

0.0%

0

0.0%

0

0.0%

1993

Phase II

215

0

0.0%

0

0.0%

0

0.0%

0

0.0%

1994

Phase II

134

1

0.7%

1

0.7%

0

0.0%

0

0.0%

1995

Phase II

212

6

2.8%

0

0.0%

0

0.0%

0

0.0%

1996

Phase II

172

5

2.9%

0

0.0%

0

0.0%

0

0.0%

1997

Phase II

279

13

4.7%

0

0.0%

0

0.0%

0

0.0%

1998

Phase II

224

7

3.1%

0

0.0%

0

0.0%

0

0.0%

1999

Phase II

278

34

12.2%

0

0.0%

0

0.0%

0

0.0%

2000

Phase II

231

52

22.5%

1

0.4%

0

0.0%

0

0.0%

2001

Phase II

343

72

21.0%

1

0.3%

0

0.0%

0

0.0%

2002

Phase II

336

80

23.8%

1

0.3%

0

0.0%

0

0.0%

2003

Phase II

327

83

25.4%

4

1.2%

0

0.0%

1

0.3%

2004

Phase II

298

91

30.5%

11

3.7%

2

0.7%

1

0.3%

2005

Phase II

312

90

28.8%

11

3.5%

13

4.2%

1

0.3%

Suggested Citation:"Appendix A: NIH SBIR Program Data." National Research Council. 2009. An Assessment of the SBIR Program at the National Institutes of Health. Washington, DC: The National Academies Press. doi: 10.17226/11964.
×

Fiscal Year

NIH Phase II SBIR Awards Over 750K

PHASE

Total Number Funded

Year Two

Year Three

Year Four

Year Five

1992

Phase II

139

0

0.0%

0

0.0%

0

0.0%

0

0.0%

1993

Phase II

215

0

0.0%

0

0.0%

0

0.0%

0

0.0%

1994

Phase II

134

0

0.0%

0

0.0%

0

0.0%

0

0.0%

1995

Phase II

212

0

0.0%

0

0.0%

0

0.0%

0

0.0%

1996

Phase II

172

0

0.0%

0

0.0%

0

0.0%

0

0.0%

1997

Phase II

279

0

0.0%

0

0.0%

0

0.0%

0

0.0%

1998

Phase II

224

0

0.0%

0

0.0%

0

0.0%

0

0.0%

1999

Phase II

278

8

2.9%

0

0.0%

0

0.0%

0

0.0%

2000

Phase II

231

8

3.5%

0

0.0%

0

0.0%

0

0.0%

2001

Phase II

343

9

2.6%

1

0.3%

0

0.0%

0

0.0%

2002

Phase II

336

23

6.8%

0

0.0%

0

0.0%

0

0.0%

2003

Phase II

327

18

5.5%

4

1.2%

0

0.0%

1

0.3%

2004

Phase II

298

24

8.1%

6

2.0%

1

0.3%

1

0.3%

2005

Phase II

312

27

8.7%

8

2.6%

11

3.5%

1

0.3%

SOURCE: National Institutes of Health.

Suggested Citation:"Appendix A: NIH SBIR Program Data." National Research Council. 2009. An Assessment of the SBIR Program at the National Institutes of Health. Washington, DC: The National Academies Press. doi: 10.17226/11964.
×

TABLE App-A-25 Phase I, Year One Supplements, 1992-2003

Fiscal Year

1992

1993

1994

1995

1996

1997

1998

1999

2000

2001

2002

2003

Number of Awards

4

6

9

7

8

15

24

16

31

33

33

30

Average ($)

67,138

64,067

47,101

25,314

43,988

100,688

131,038

96,728

118,537

134,049

163,440

95,711

Maximum ($)

142,502

150,000

121,237

82,000

118,886

214,957

530,198

375,000

574,670

600,000

713,490

370,349

Minimum ($)

26,731

8,112

2,780

6,779

6,417

15,470

9,414

634

10,268

10,000

9,809

2,200

Total ($)

268,550

384,402

423,913

177,196

351,906

1,510,314

3,144,900

1,547,643

3,674,641

4,423,627

5,393,530

2,871,315

SOURCE: National Institutes of Health.

Suggested Citation:"Appendix A: NIH SBIR Program Data." National Research Council. 2009. An Assessment of the SBIR Program at the National Institutes of Health. Washington, DC: The National Academies Press. doi: 10.17226/11964.
×

TABLE App-A-26 Phase II, Year One Grants, 1992-2003

All Phase II, year one grants

Fiscal Year

1992

1993

1994

1995

1996

1997

Number of Grants

137

215

131

210

173

280

Average ($)

249,361

244,363

269,611

345,070

349,374

375,304

Amended Phase II, year one grants

Fiscal Year

1992

1993

1994

1995

1996

1997

Number of Grants

29

55

22

48

51

89

Percent of all

21.2

25.6

16.8

22.9

29.5

31.8

Average ($)

238,893

247,948

255,816

354,890

336,933

358,916

Percent all av.

95.8

101.5

94.9

102.8

96.4

95.6

Maximum ($)

286,292

500,000

326,203

647,634

495,215

611,874

Minimum ($)

129,427

112,898

2,000

93,848

3,646

7,666

Sum ($)

6,927,902

13,637,125

5,627,959

17,034,712

17,183,579

31,943,518

SOURCE: National Institutes of Health.

Suggested Citation:"Appendix A: NIH SBIR Program Data." National Research Council. 2009. An Assessment of the SBIR Program at the National Institutes of Health. Washington, DC: The National Academies Press. doi: 10.17226/11964.
×

1998

1999

2000

2001

2002

2003

237

289

267

381

358

349

379,972

410,335

448,377

437,573

461,216

495,834

1998

1999

2000

2001

2002

2003

45

60

62

100

88

82

19.0

20.8

23.2

26.2

24.6

23.5

377,707

385,556

391,078

402,757

462,258

461,427

99.4

94.0

87.2

92.0

100.2

93.1

514,581

864,785

591,768

822,158

1,152,230

1,230,000

48,387

12,869

9,782

31,418

23,719

204,950

16,996,826

23,133,378

24,246,844

40,275,684

40,678,701

37,837,035

Suggested Citation:"Appendix A: NIH SBIR Program Data." National Research Council. 2009. An Assessment of the SBIR Program at the National Institutes of Health. Washington, DC: The National Academies Press. doi: 10.17226/11964.
×

TABLE A pp-A-27 Phase II Contracts, 1992-2000

Fiscal Year

1992

1993

1994

1995

1996

1997

1998

1999

2000

Number of Awards

27

34

21

26

23

24

28

21

28

Average ($)

205,473

222,926

210,814

337,065

304,616

377,640

359,969

414,538

324,965

Maximum ($)

477,019

499,085

500,000

739,693

750,000

1,184,286

750,000

798,773

749,868

Minimum ($)

14,834

9,660

13,915

10,000

7,050

9,793

7,253

4,245

87,992

Total ($)

5,547,783

7,579,467

4,427,086

8,763,693

7,006,158

9,063,353

10,079,133

8,705,294

9,099,027

SOURCE: National Institutes of Health.

Suggested Citation:"Appendix A: NIH SBIR Program Data." National Research Council. 2009. An Assessment of the SBIR Program at the National Institutes of Health. Washington, DC: The National Academies Press. doi: 10.17226/11964.
×

TABLE App-A-28 Phase II Awards by IC, 1992-2003

IC

Number of Awards

Percent of Total

Number of Applications

Success Rate (%)

1992

1993

1994

1995

1996

1997

1998

1999

2000

2001

2002

2003

Awards

AA

3

3

1

1

2

5

2

4

5

4

4

2

36

1.2

92

39.1

AG

8

10

4

14

9

10

12

11

10

15

19

14

136

4.5

300

45.3

AI

16

23

17

18

20

28

27

30

23

30

26

22

280

9.3

667

42.0

AR

4

4

2

3

1

7

3

6

6

7

10

8

61

2.0

251

24.3

AT

 

 

 

 

 

 

 

 

2

 

3

1

6

0.2

10

60.0

CA

15

40

16

45

31

53

45

46

49

56

54

51

501

16.6

1,378

36.4

DA

5

13

3

7

6

11

9

5

9

14

14

15

111

3.7

232

47.8

DC

2

4

4

4

4

4

6

4

4

9

5

6

56

1.9

151

37.1

DE

3

6

2

3

4

4

3

4

1

4

9

8

51

1.7

175

29.1

DK

9

13

8

12

13

18

14

20

16

23

26

24

196

6.5

450

43.6

EB

 

 

 

 

 

 

 

 

 

 

6

6

12

0.4

25

48.0

ES

1

4

2

3

3

3

6

4

4

6

8

11

55

1.8

135

40.7

EY

5

6

1

5

4

9

9

9

11

13

6

12

90

3.0

242

37.2

GM

16

13

17

19

16

25

17

26

23

37

20

26

255

8.4

567

45.0

HD

6

11

10

12

9

15

15

14

21

26

25

21

185

6.1

464

39.9

HG

2

4

1

4

1

4

4

6

6

5

3

7

47

1.6

76

61.8

HL

23

35

18

27

21

42

28

45

31

59

47

53

429

14.2

1,018

42.1

LM

 

 

 

 

 

 

 

 

 

2

 

2

4

0.1

20

20.0

MD

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1

0.0

MH

8

9

10

11

11

16

14

20

18

23

13

18

171

5.6

330

51.8

NR

 

1

 

 

2

1

1

2

2

3

3

3

18

0.6

51

35.3

NS

7

12

7

10

9

15

12

17

18

20

31

17

175

5.8

384

45.6

RR

4

4

6

9

7

10

7

11

7

22

19

22

128

4.2

326

39.3

Shared

 

 

2

3

 

 

3

5

1

3

7

 

24

0.8

 

 

Total

137

215

131

210

173

280

237

289

267

381

358

349

3,027

100

 

 

SOURCE: National Institutes of Health.

Suggested Citation:"Appendix A: NIH SBIR Program Data." National Research Council. 2009. An Assessment of the SBIR Program at the National Institutes of Health. Washington, DC: The National Academies Press. doi: 10.17226/11964.
×

TABLE App-A-29 Conversion Fates of Top 20 Phase II Winners, 1992-2003

Organization

Number of Phase II Awards

Number of Phase I Awards

Conversion Rate (%)

NEW ENGLAND RESEARCH INSTITUTES, INC.

34

42

81.0

INFLEXXION, INC.

32

44

72.7

RADIATION MONITORING DEVICES, INC.

30

56

53.6

OREGON CENTER FOR APPLIED SCIENCE

27

44

61.4

INSIGHTFUL CORPORATION

22

40

55.0

LYNNTECH, INC.

17

51

33.3

PANORAMA RESEARCH, INC.

15

69

21.7

INOTEK PHARMACEUTICALS CORPORATION

14

63

22.2

SOCIOMETRICS CORPORATION

13

16

81.3

ABIOMED, INC.

13

13

100.0

PERSONAL IMPROVEMENT COMPUTER SYSTEMS

13

25

52.0

CREARE, INC.

13

40

32.5

CLEVELAND MEDICAL DEVICES, INC.

13

23

56.5

INDIVIDUAL MONITORING SYS, INC. (IM SYS)

12

14

85.7

BIOTEK, INC.

12

29

41.4

SURMODICS, INC.

11

30

36.7

ADVANCED MEDICAL ELECTRONICS CORPORATION

11

18

61.1

ELECTRICAL GEODESICS, INC.

11

19

57.9

WESTERN RESEARCH COMPANY, INC.

11

20

55.0

PHYSICAL SCIENCES, INC.

11

25

44.0

Total (top 20 award winners)

335

681

49.2

All Awards

3,027

 

 

Top 20 as percent of all Phase II awards

11.1

 

 

SOURCE: National Institutes of Health.

Suggested Citation:"Appendix A: NIH SBIR Program Data." National Research Council. 2009. An Assessment of the SBIR Program at the National Institutes of Health. Washington, DC: The National Academies Press. doi: 10.17226/11964.
×

TABLE App-A-30 Phase II Awards by State, 1992-2005

State

Number of Awards by Fiscal Year

Grand Total

Percent of Total

1992

1993

1994

1995

1996

1997

1998

1999

2000

2001

2002

2003

2004

2005

ALABAMA

2

2

4

6

4

3

3

3

4

6

7

5

5

3

57

0.7

ARIZONA

3

7

6

2

2

5

7

13

14

8

17

18

10

11

123

1.6

ARKANSAS

 

 

1

1

 

 

 

 

 

 

1

1

 

2

6

0.1

CALIFORNIA

39

62

53

60

66

94

119

99

94

120

137

137

155

142

1,377

17.8

COLORADO

3

5

5

5

9

10

11

16

17

15

17

17

15

15

160

2.1

CONNECTICUT

8

9

9

12

12

8

7

6

9

9

5

7

12

11

124

1.6

DELAWARE

 

 

 

 

2

2

1

3

4

3

2

2

3

3

25

0.3

DIST OF COL

1

2

4

2

2

6

6

6

14

9

12

8

8

5

85

1.1

FLORIDA

6

13

10

4

3

10

9

4

11

10

9

9

10

11

119

1.5

GEORGIA

1

1

3

3

1

4

6

8

8

6

5

5

7

8

66

0.9

HAWAII

2

2

2

3

2

1

 

1

2

2

2

1

2

3

25

0.3

IDAHO

 

1

1

 

 

 

 

1

1

 

 

 

1

1

6

0.1

ILLINOIS

7

10

9

6

6

11

13

17

17

18

17

19

15

6

171

2.2

INDIANA

4

2

 

3

5

5

4

4

5

5

7

6

6

9

65

0.8

IOWA

2

1

 

 

 

1

2

2

1

3

4

2

2

1

21

0.3

KANSAS

 

 

 

2

2

2

2

1

2

3

4

4

4

3

29

0.4

KENTUCKY

1

2

1

 

1

1

 

1

1

3

4

1

4

5

25

0.3

LOUISIANA

1

2

1

1

 

1

1

 

1

2

3

3

1

3

20

0.3

MAINE

1

1

2

2

 

2

3

2

2

1

3

4

1

1

25

0.3

MARYLAND

23

31

34

30

28

26

37

30

29

42

48

43

52

52

505

6.5

MASSACHUSETTS

57

70

52

60

80

94

86

84

99

118

121

105

100

103

1,229

15.9

MICHIGAN

8

10

7

8

11

15

19

14

10

14

13

19

18

24

190

2.5

MINNESOTA

10

9

9

8

10

16

12

8

8

10

13

16

14

20

163

2.1

MISSISSIPPI

 

 

 

 

 

 

 

 

 

 

 

1

1

 

2

0.0

MISSOURI

2

1

2

 

 

1

3

3

6

3

7

7

4

5

44

0.6

MONTANA

 

 

 

 

1

1

1

2

1

2

2

1

2

2

15

0.2

NEBRASKA

1

1

1

2

2

2

2

1

3

4

2

1

4

3

29

0.4

Suggested Citation:"Appendix A: NIH SBIR Program Data." National Research Council. 2009. An Assessment of the SBIR Program at the National Institutes of Health. Washington, DC: The National Academies Press. doi: 10.17226/11964.
×

State

Number of Awards by Fiscal Year

Grand Total

Percent of Total

1992

1993

1994

1995

1996

1997

1998

1999

2000

2001

2002

2003

2004

2005

NEVADA

1

1

2

2

1

1

 

 

1

3

4

2

2

 

20

0.3

NEW HAMPSHIRE

1

2

2

6

6

4

6

7

6

7

8

12

12

8

87

1.1

NEW JERSEY

12

7

8

8

7

6

9

19

21

20

27

21

16

19

200

2.6

NEW MEXICO

 

1

2

2

4

4

2

1

4

5

5

6

5

4

45

0.6

NEW YORK

13

21

23

20

23

26

22

22

27

32

42

40

36

36

383

5.0

NORTH CAROLINA

7

9

13

8

6

14

16

15

13

17

24

23

23

31

219

2.8

NORTH DAKOTA

 

 

 

 

 

 

 

 

 

 

 

 

1

2

3

0.0

OHIO

4

8

8

11

10

14

18

18

17

16

29

29

19

19

220

2.9

OKLAHOMA

1

2

3

1

1

 

1

1

 

1

2

1

3

4

21

0.3

OREGON

6

7

8

11

12

14

19

18

21

21

21

20

23

27

228

3.0

PENNSYLVANIA

13

7

7

12

16

13

17

20

18

27

38

34

34

32

288

3.7

PUERTO RICO

 

 

 

 

 

 

 

 

1

1

 

 

 

 

2

0.0

RHODE ISLAND

1

1

 

 

 

 

 

2

4

4

6

7

10

8

43

0.6

SOUTH CAROLINA

 

 

 

 

 

 

 

 

1

1

6

7

5

6

26

0.3

SOUTH DAKOTA

 

 

 

 

 

 

 

2

2

1

2

1

1

1

10

0.1

TENNESSEE

2

2

4

4

1

1

5

5

3

2

2

5

6

4

46

0.6

TEXAS

13

12

12

16

13

15

17

18

23

27

25

32

36

37

296

3.8

UTAH

8

13

9

7

5

2

5

8

9

12

16

9

5

4

112

1.5

VERMONT

2

1

2

4

3

2

1

 

1

1

1

5

6

4

33

0.4

VIRGINIA

6

10

18

21

15

10

12

14

13

22

24

32

36

23

256

3.3

WASHINGTON

5

11

12

14

14

15

30

34

26

30

42

42

36

35

346

4.5

WISCONSIN

1

1

2

3

4

6

7

6

12

16

10

17

20

17

122

1.6

WYOMING

 

 

 

 

 

 

 

 

1

1

1

1

1

1

6

0.1

Grand Total

278

360

351

370

390

468

541

539

587

683

797

788

792

774

7,718

100.0

SOURCE: National Institutes of Health.

Suggested Citation:"Appendix A: NIH SBIR Program Data." National Research Council. 2009. An Assessment of the SBIR Program at the National Institutes of Health. Washington, DC: The National Academies Press. doi: 10.17226/11964.
×

TABLE App-A-31 NIH—Target Groups

Size of Affected Populations

In Commercialization

In Use

Total

Number

Percent

Number

Percent

Number

Percent

MISSING

1

0.5

0

0.0

1

0.3

Under 10,000 persons

30

16.3

42

26.6

72

21.1

10,000-49,999

23

12.5

21

13.3

44

12.9

50,000-199,999

9

4.9

17

10.8

26

7.6

200,000-499,999

13

7.1

14

8.9

27

7.9

500,000 or more

76

41.3

44

27.8

120

35.1

Not sure

32

17.4

20

12.7

52

15.2

 

184

100.0

158

100.0

342

100.0

SOURCE: National Institutes of Health, National Survey to Evaluate the NIH SBIR Program: Final Report, July 2003.

TABLE App-A-32 High-impact Projects—By Target Sector

Population

Number of High-impact Respondents

All Respondents (#)

Percent of High-impact

Percent of All

Outpatients

4

28

9.1

11.2

Inpatients

1

22

2.3

8.8

Hospital personnel

4

10

9.1

4.0

Research labs

2

67

4.5

26.9

Diagnostic labs

4

15

9.1

6.0

Medical practitioners

7

24

15.9

9.6

Homecare providers

1

1

2.3

0.4

Other

2

3

4.5

1.2

Other health services

4

12

9.1

4.8

General public

8

26

18.2

10.4

Educators

2

7

4.5

2.8

Worksites

0

1

0.0

0.4

Schools, universities

1

11

2.3

4.4

Other companies, other technologies

2

7

4.5

2.8

Health researchers

1

5

2.3

2.0

MISSING

1

10

2.3

4.0

Total

44

249

100.0

100.0

NOTE: High-impact respondents are those with products in use, who expect to affect more than 500,000 people.

SOURCE: National Institutes of Health, National Survey to Evaluate the NIH SBIR Program: Final Report, July 2003.

Suggested Citation:"Appendix A: NIH SBIR Program Data." National Research Council. 2009. An Assessment of the SBIR Program at the National Institutes of Health. Washington, DC: The National Academies Press. doi: 10.17226/11964.
×

TABLE App-A-33 NIH—Field of Business

Q2. Field of Business

 

 

Q2. Text:

 

Number of Companies

Percent

Which of the following best describes this company’s major field of business?

Biotechnology

175

22.8

Chemical technology

12

1.6

Computer hardware, software

88

11.5

 

Diagnostics

43

5.6

 

Engineering, fabrication

13

1.7

 

Environment, ergonomics

20

2.6

 

Health care

21

2.7

 

Information & research

85

11.1

 

Instrumentation

17

2.2

 

Medical devices

145

18.9

 

Medical education, health promotion

65

8.5

 

Other

25

3.3

 

Pharmaceuticals

58

7.6

 

Total companies responding

767

100

 

SOURCE: National Institutes of Health, National Survey to Evaluate the NIH SBIR Program: Final Report, July 2003.

Suggested Citation:"Appendix A: NIH SBIR Program Data." National Research Council. 2009. An Assessment of the SBIR Program at the National Institutes of Health. Washington, DC: The National Academies Press. doi: 10.17226/11964.
×

TABLE App-A-34 NIH—Other SBIR Awards

How Many Related Phase II Awards?

NIH Survey Breakout—Phase I and Phase II

Number of Awards

NIH Survey

NRC Survey

Number of Awards

Related Phase I Awards

Related Phase II Awards

Number of Companies

Percent

Number of Companies

Percent

Number of Companies

Percent

Number of Companies

Percent

 

 

 

 

 

0

2

0.5

143

35.8

1

152

59.4

92

56.8

1

156

39.1

152

38.1

2

65

25.4

30

18.5

2

106

26.6

65

16.3

3

1 9

7.4

11

6.8

3

6 8

17.0

19

4.8

4

8

3.1

8

4.9

4

19

4.8

8

2.0

5

4

1.6

12

7.4

5

20

5.0

4

1.0

6

2

0.8

0

0.0

6

1 3

3.3

2

0.5

7

1

0.4

1

0.6

7

3

0.8<